8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)
Published . Updated .
Key takeaways
- 8-K - Milestone Pharmaceuticals filed an 8-K with the SEC on Nov 13 (a notice of a material company event).
- Exposed: MIST
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Milestone Pharmaceuticals filed an 8-K with the SEC on Nov 13 (a notice of a material company event).
Directly affected
- MIST Milestone Pharmaceuticals-15.0% 12d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+25.0% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+9.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+6.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.7% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MIST | +16.85% | +4.97% | base | after close | after close | after close | after close |
| XLV | -1.60% | +0.57% | base | after close | after close | after close | after close |
| XBI | +0.68% | +2.56% | base | after close | after close | after close | after close |
| LLY | -5.27% | +0.16% | base | after close | after close | after close | after close |
| JNJ | -2.55% | -0.98% | base | after close | after close | after close | after close |
| PFE | +1.93% | +1.84% | base | after close | after close | after close | after close |
| MRK | -0.13% | +0.71% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-13 AccNo: 0001104659-26-126519 Size: 304 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Milestone Pharmaceuticals (MIST) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | three days earlier | -0.98% | final price |
| JNJ | five days earlier | -2.55% | final price |
| LLY | three days earlier | +0.16% | final price |
| LLY | five days earlier | -5.27% | final price |
| Milestone Pharmaceuticals (MIST) | three days earlier | +4.97% | final price |
| Milestone Pharmaceuticals (MIST) | five days earlier | +16.85% | final price |
| MRK | three days earlier | +0.71% | final price |
| MRK | five days earlier | -0.13% | final price |
| PFE | three days earlier | +1.84% | final price |
| PFE | five days earlier | +1.93% | final price |
| XBI | three days earlier | +2.56% | final price |
| XBI | five days earlier | +0.68% | final price |
| XLV | three days earlier | +0.57% | final price |
| XLV | five days earlier | -1.60% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 24 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 37 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 44 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 84 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 86 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)”
Companies mentioned with this story
- MIST Milestone Pharmaceuticals
In “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer),” Milestone Pharmaceuticals (MIST) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MIST
How “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” reaches Milestone Pharmaceuticals (MIST)
The 13 Nov 2026 story “8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” names Milestone Pharmaceuticals (MIST) because of this story.
For Milestone Pharmaceuticals (MIST), the reason on file says SEC 8-K filing -> direct issuer disclosure -> MIST
Price levels for Milestone Pharmaceuticals (MIST)
MIST traded between 0.66 and 0.82 across 11 sessions. The latest close on file is 0.68.
How strong the case is around Milestone Pharmaceuticals (MIST)
14 out of 100
“8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.